AXS-12 Reduces Cataplexy, Sleepiness in Narcolepsy

(MedPage Today) -- SAN DIEGO--AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed.
From baseline, patients treated...